Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies
- 1 March 2004
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 61 (3) , 137-154
- https://doi.org/10.1002/ddr.10344
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Structural Analysis of Human IgG-Fc Glycoforms Reveals a Correlation Between Glycosylation and Structural IntegrityPublished by Elsevier ,2003
- Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular ToxicityJournal of Biological Chemistry, 2002
- Modulation of antigenicity related to changes in antibody flexibility upon lyophilization11Edited by W. BaumeisterJournal of Molecular Biology, 2001
- Effect of Mannitol Crystallization on the Stability and Aerosol Performance of a Spray-Dried Pharmaceutical Protein, Recombinant Humanized anti-IgE Monoclonal AntibodyJournal of Pharmaceutical Sciences, 1998
- Recent developments in capillary isoelectric focusing with whole‐column imaging detectionElectrophoresis, 1998
- Buffer exchange using size exclusion chromatography, countercurrent dialysis, and tangential flow filtration: Models, development, and industrial applicationBiotechnology & Bioengineering, 1995
- Electrospray Ionization Mass Spectrometry of Recombinantly Engineered Antibody FragmentsAnalytical Chemistry, 1994
- Nature of Aggregates Formed during Storage of Freeze-Dried Ribonuclease AJournal of Pharmaceutical Sciences, 1991
- Shear-induced protein-protein interaction at the air-water interfaceBiochimica et Biophysica Acta (BBA) - Biomembranes, 1974
- Equilibrium centrifugation of nonideal systems. Donnan effect in self-associating systemsBiochemistry, 1971